BioNexus Gene Lab Corp. (BGLC) vs FBS Global Limited Ordinary Shares (FBGL)
A side-by-side comparison of BioNexus Gene Lab Corp. and FBS Global Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGLC
BioNexus Gene Lab Corp.
$1.28IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT
FBGL
FBS Global Limited Ordinary Shares
$3.55IndustrialsDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BGLC vs FBGL
growth of $100 · dividends reinvested · last 2yBGLC -66.4% (-42.0%/yr)FBGL -89.7% (-67.9%/yr)BGLC compounded faster over this window
BGLC FBGL
BGLC vs FBGL: by the numbers
- •FBGL is the larger company ($5M vs $3M market cap).
- •Both run net losses; FBGL's is the smaller (-7.87% vs -82.36% net margin).
- •FBGL grew revenue faster over the past five years (36.13% vs -31.68% CAGR).
Metrics side by side
Valuation
| Metric | BGLC | FBGL |
|---|---|---|
| P/S ratio | 0.99 | N/A |
| P/B ratio | 0.40 | 0.48 |
Profitability
| Metric | BGLC | FBGL |
|---|---|---|
| Gross margin | 11.64% | 10.16% |
| Operating margin | -42.54% | -7.47% |
| Net margin | -82.36% | -7.87% |
| ROE | -33.11% | -15.74% |
| ROIC | -32.71% | -14.78% |
Growth (annualized)
| Metric | BGLC | FBGL |
|---|---|---|
| Revenue CAGR (5Y) | -31.68% | 36.13% |
| Total return CAGR (5Y) | -61.00% | N/A |
Frequently asked
- Which has grown faster, BGLC or FBGL?
- Over the past five years, FBGL grew revenue faster — BGLC at a -31.68% CAGR versus FBGL at 36.13%.
Go deeper
Dig into the metrics
BioNexus Gene Lab ROEFBS Global Limited Ordinary Shares ROEBioNexus Gene Lab operating marginFBS Global Limited Ordinary Shares operating marginBioNexus Gene Lab revenue growthFBS Global Limited Ordinary Shares revenue growthBioNexus Gene Lab free cash flowFBS Global Limited Ordinary Shares free cash flow
BioNexus Gene Lab & FBS Global Limited Ordinary Shares appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.